Although irritable bowel syndrome (IBS) is not a life-threatening condition, it can have a serious impact on a patient's daily activities and quality of life.
This effect on quality of life has not been compared previously across different cultures.
We compared measures of health-related quality of life and health care resource utilization using a cross-sectional point-in-time postal survey of a random sample of 500 members of the International Foundation for Functional Gastrointestinal Disorders in the US and 500 members of the IBS Network support group in the UK.
The analysis was limited to persons who reported that a physician had told them they had IBS.
A general health status questionnaire, the SF-36, and a disease-specific questionnaire, the Irritable Bowel Syndrome Quality of Life questionnaire (IBSQOL), were self-administered as part of the survey to measure health-related quality of life.
Results on the SF-36 were compared with published normative data for adults in the US and UK with and without chronic diseases.
The UK group (n=343) reported significantly poorer quality of life on the SF-36 and on four parameters of the IBSQOL than did the US group (n=287).
The general health status of persons with IBS in either country was much poorer compared with that of general populations in the respective countries.
Mots-clés Pascal : Côlon irritable, Complication, Détérioration, Qualité vie, Incidence, Demande thérapeutique, Corrélation, Homme, Appareil digestif pathologie, Intestin pathologie
Mots-clés Pascal anglais : Irritable bowel syndrome, Complication, Deterioration, Quality of life, Incidence, Therapeutical request, Correlation, Human, Digestive diseases, Intestinal disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 99-0097114
Code Inist : 002B13B03. Création : 31/05/1999.